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Accumulating evidence suggests that the Rad9-Rad1-Hus1
(9-1-1) checkpoint complex, known to be a sensor of DNA dam-
age, is also a component of DNA repair systems. Recent results
show that 9-1-1 interacts with several base excision repair pro-
teins. It binds the DNA glycosylase MutY homolog, and stimu-
lates DNApolymerase, flap endonuclease 1, andDNA ligase I.
9-1-1 resembles proliferating cell nuclear antigen (PCNA),
which stimulates some of these same repair enzymes, and is
loaded onto DNA in a similar manner. The complex of 9-1-1
withDNA ligase I canbe immunoprecipitated fromhumancells.
Moreover, UV irradiation stimulates 9-1-1ligase I complex for-
mation, suggesting a role for 9-1-1 in DNA repair. Examining
the nature of 9-1-1 interaction with DNA ligase I, we show that
there is a similar degree of stimulation on ligation substrates
with different structures, and that there is specificity for DNA
ligase I. 9-1-1 improves the binding of DNA ligase I to nicked
double strand DNA. Furthermore, although high concentra-
tions of casein kinase II strongly inhibits DNA ligase I activity, it
does not affect the ability of 9-1-1 to stimulate. This suggests
that 9-1-1 is also an activator of DNA ligase I during DNA dam-
age. Unlike PCNA, 9-1-1 stimulates DNA ligase I activity to the
same extent on both linear and circular substrates, indicating
that encirclement is not a requirement for stimulation. These
data are consistentwith adirect role for 9-1-1 inDNArepair, but
possibly employing a different mechanism than PCNA.
Proliferating cell nuclear antigen (PCNA)2 is a toroidal slid-
ing clamp that serves as a platform for the sequential actions of
proteins involved in eukaryotic DNA replication and repair.
DNA damage produces a response that inhibits DNA replica-
tion while allowing DNA repair. It includes induction of p21, a
protein thatmediates growth arrest. A domain of p21 binds and
inactivates PCNA (1, 2). Expression of this domain can cause
cells to arrest inG1 phase, suggesting that inhibition of PCNA is
part of the damage response (3–5). PCNA binds and stimulates
proteins with dual roles in DNA replication and repair, e.g. the
flap endonuclease FEN1 and DNA ligase I (6). In an effort to
identify whether there is a substitute platform forDNA repair if
PCNA were inactivated, we considered the Rad9-Rad1-Hus1
(9-1-1) checkpoint complex.
Rad9-Rad1-Hus1 (9-1-1) bears a strong structural, but not
sequence, resemblance to PCNA. It is loaded to encircle dou-
ble-strandedDNA in vitro by a variant of RFC, the PCNAclamp
loader, called Rad17-RFC (7–9). Rad17-RFC can recruit 9-1-1
onto chromatin, and this action is independent of the phospho-
rylation of Rad17, which can be phosphorylated by ATM and
ATR after DNA damage in vivo (10, 11). These studies show
that 9-1-1 can load on chromatin, recognize DNA damage, and
then activate the checkpoint pathway, suggesting that 9-1-1 is a
damage sensor (12).
Other results point to a direct role of 9-1-1 as a mediator and
possible platform for DNA repair. 9-1-1 stimulates or associ-
ates with enzymes involved in nearly every step of the long
patch base excision repair (LP-BER) pathway (13). In this path-
way, damaged bases are removed by glycosylases, the abasic site
is cleaved by an abasic nuclease, and a short patch of synthesis is
carried out by DNA polymerase , , or , displacing a 5 flap
that is removed by FEN1. The nick produced by this reaction is
sealed by DNA ligase I (14). The DNA glycosylase MutY hom-
olog in yeast co-immunoprecipitatedwith the yeast 9-1-1 hom-
olog (15). The activity and reaction specificity of DNA polym-
erase  was altered by 9-1-1 (16). 9-1-1 bound and greatly
stimulated FEN1 (17, 18). The binding sites for PCNA and
9-1-1 on FEN1 were identified and found to be distinct (16).
Finally, 9-1-1 was shown to bind DNA ligase I and stimulate
ligation (19).
DNA ligase I is toroidal and can encircle a nicked DNA sub-
strate (20). DNA ligase I activity is high in proliferating cells
(21–23), and the level correlates with the rate of cell prolifera-
tion (24). In addition, retarded joining ofOkazaki fragments has
been observed in 46BR cells, deficient in DNA ligase I (25).
These facts suggest that DNA ligase I participates in Okazaki
fragment maturation. In reconstituted replication systems,
DNA ligase I joins Okazaki fragments (26–28). DNA ligase I
was shown to function in BER and nucleotide excision repair
(29, 30). Results in vitro also suggest that DNA ligase I partici-
pates in these pathways (31–34).
Recently it was reported that purified 9-1-1 binds to and
stimulates DNA ligase I (19). Here we address the specificity of
the stimulation and show that the complex of DNA ligase I and
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9-1-1 can be immunoprecipitated from cell extracts. We also
address whether the 9-1-1 needs to be loaded onto the DNA for
stimulation.
EXPERIMENTAL PROCEDURES
Substrate Preparation—All oligonucleotides were purchased
from Integrated DNA Technologies (Coralville, IA). ATP was
from Roche Molecular Biochemicals. X174 single-stranded
DNAwas fromNewEngland BioLabs.Micro Bio-Spin columns
(Bio-Lab) were used for purification of labeled DNA. T4 ligase
and CK2 were from Roche Molecular Biochemicals. All the
other reagents were the best available commercial grade.
Labeling and purifying of substrates were performed as
described (35). Oligomer sequences are listed in Table 1. Each
substrate consisted of a downstreamprimer (D), a template (T),
and an upstream primer (U).
Enzyme Expression and Purification—Human DNA ligase I
was cloned into theT7 expression plasmid pET-15b (Novagen).
The final expression vector pHIS-hLIG1 was grown in
Escherichia coli BL21 strain. Recombinant humanDNA ligase I
was purified as previously described (36). Rad9-Rad1-Hus1 was
expressed and purified as previously described (37).
Enzyme Assays—Reactions were performed in 30 mM
HEPES (pH 7.5), 40 mM KCl, 4 mM MgCl2, 5% glycerol, and
0.1 mg/ml bovine serum albumin with 0.1 mM ATP. Enzyme
stocks were diluted in 30mMHEPES (pH 7.5), 5% glycerol, 40
mM KCl, and 0.1 mg/ml bovine serum albumin. Each reac-
tion contained 10 fmol of substrate in a 20-l reaction and
amounts of the enzymes as indicated in the figure legends.
All the reactions were incubated at 37 °C for 10 min, and the
products were resolved on 15% polyacrylamide, 7 M urea
denaturing gels. The extent of ligation was quantitated using
a PhosphorImager (GE Healthcare) and ImageQuant version
1.2 software from GE Healthcare. All enzyme assays were
performed at least in triplicate, and representative assays are
shown.
Electrophoretic Mobility Shift Assay—Enzyme/DNA mix-
tures were incubated at 37 °C for 10 min in binding buffer (30
mM HEPES, pH 7.5, 5% glycerol, 40 mM KCl, 0.1 mg/ml bovine
serum albumin with 0.1 mM ATP). Samples were then run on a
12% polyacrylamide gel in 0.5  TBE buffer (44.5 mM Tris
borate, pH 8.3, 1 mM Na2EDTA). The gel was analyzed by
PhosphorImager.
Immunoprecipitation—TK6 cells were incubated at 37 °C for
1 h and then harvested after treated by 9 gray-irradiation or 50
J/m2UV. Nuclear extracts of TK6 cells were prepared by stand-
ard methods (38). Protein G beads (Roche Diagnostics) were
equilibrated with buffer C  0.01%Nonidet P-40 prior to addi-
tion of antibody. Five l of human Rad9 monoclonal antibody
(Calbiochem, San Diego) and hemagglutinin monoclonal anti-
body (Cell Signaling Technology, Inc.) were added to the pro-
tein G beads and incubated at 4 °C for 2 h. The beads were
washed twice with buffer C  0.01% Nonidet P-40. 5 mg of
nuclear extract was mixed with protein G beads and incubated
overnight at 4 °C. The beads were washed 3 times with buffer C
 0.01%Nonidet P-40 and thenwith buffer A 0.01%Nonidet
P-40. The beads were then collected by centrifugation. Sample
buffer was added and then the sampleswere run on SDS-PAGE,
and analyzed by DNA ligase I antibody (10H5, GeneTex, Inc.,
San Antonio, TX) and Rad9 antibody, respectively.
Pulldown Assays—Because humanDNA ligase I was tagged by
histidine and human Rad1was tagged by FLAG, 20l of histidine
or FLAG antibody-conjugated beads were used in these experi-
ments. Histidine antibody-conjugated agarose beads (Novus Bio-
logicals, Inc.) and FLAG antibody-conjugated agarose beads
(Sigma)wereequilibratedwithbufferC0.1%NonidetP-40.One
pmolofpurified9-1-1orDNAligase Iwas incubatedat 4 °C for1h
with FLAGantibody-conjugated agarose beads andhistidine anti-
body-conjugated agarose beads, respectively. After being washed
twicewithbufferC0.1%NonidetP-40, FLAGbeadsorhistidine
beadswere further incubatedwith 2 pmol of purifiedDNA ligase I
or 9-1-1 at 4 °C for 1 h. Beadswerewashed three timeswith buffer
C  0.1% Nonidet P-40 and once with buffer A  0.1% Nonidet
P-40. Finally beads were suspended in SDS sample buffer. After
SDS-PAGE, samples were analyzed by DNA ligase I monoclonal
antibody (10H5, GeneTex, Inc.) and Rad1 antibody (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA).
RESULTS
9-1-1 Interaction with DNA Ligase I Is Promoted by DNA
Damage—PCNA has been shown to interact directly with both




D1 30-mers CAT ACC GCT GAT TCT GCG TTT GCT GAT GAA
D2 30-mers TAT ACC GCT GAT TCT GCG TTT GCT GAT GAA
D3 27-mers CTG CTG CTG GTA AAA CGA CGG CCA GTG
D4 35-mers ACT TGC CCG TGC CAC CAT CCC GAC GCC ACC TCC TG
D5 35-mers dCT TGC CCG TGC CAC CAT CCC GAC GCC ACC TCC TGa
D6 39-mers ACT GGG AAA CAT ACC GCT GAT TCT GCG TTT GCT GAT GAA
Templates
T1 60-mers GTT CAT CAG CAA ACG CAG AAT CAG CGG TAT GGC TCT TCT CAT ATT GGC GCT ACT GCA AAG
T2 64-mers GCA CTG GCC GTC GTT TTA CCA GCA GCA GCA GCA GCA GCA GCA GCA GCA GGG TCG TGA CTG GGA A
T3 56-mers GCT GGC ACG GTC GGA TTT TGT GAA CGG GCA CGG TGG TAG GGC TGC GGT GGA GGA CG
Upstream primers
U1 29-mers CTT TGC AGT AGC GCC AAT ATG AGA AGA GC
U2 45-mers TTC CCA GTC ACG ACC CTG CTG CTG CTG CTG CTG CTG CTG CTG CTG
U3 20-mers CGA CCG TGC CAG CCT AAA AC
U4 59-mers CTT TGC AGT AGC GCC AAT ATG AGA AGA GCC ATA CCG CTG ATT CTG CGT TTG CTG ATG AA
a d in downstream primer D5 represents 1,2-dideoxyribose (dSpacer).
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ate stimulation of both catalytic activities (39–42). Previous
pulldown experiments showed that purified His-tagged DNA
ligase I interacts with purified 9-1-1 (19). Here we tested
whether the two proteins interact in cell extracts. Human Rad9
monoclonal antibody was used for immunoprecipitation (Fig.
1A). The results showed that DNA ligase I was immunoprecipi-
tated from either untreated TK6 cells (lane 1) or cells exposed
to ultraviolet (UV) light (lanes 2 and 3). Significantly, the
amount of DNA ligase IRad9 complex increased 2-fold in UV-
irradiated cells compared with that in untreated cells. These
results indicate that 9-1-1 and DNA ligase I do interact in vivo
and that this interaction is stimulated by UV damage. The
amount of DNA ligase IRad9 did not change in ionizing radia-
tion (IR)-treated cells. This suggests that the nature of the dam-
age determines the amount of complex formation.
We also confirmed the interaction between purified DNA
ligase I and 9-1-1 using a pulldown assay. We found that Rad1
could be pulled down only in the presence of DNA ligase I (Fig.
1B, lane 1). Similarly, we found that DNA ligase I could be
pulled down only in the presence of 9-1-1 (Fig. 1B, lane 5), but
not in its absence (Fig. 1B, lane 6). These results show that 9-1-1
directly interacts with DNA ligase I.
9-1-1 Stimulates DNA Ligase I without an Apparent Change
in Mechanism—To assess the mechanism of stimulation of
human DNA ligase I by 9-1-1, we first confirmed the robust
stimulation reported on a linear nicked substrate (19) (Fig. 2,
lanes 7–12). We then asked whether 9-1-1 altered the specific-
ity of ligation for different types of substrates. We considered
three possibilities. First, the substrate equilibrates into many
structures only a few of which are ligatable. For this we
employed a substrate with overlapping primers containing tan-
demCTG triplet repeats (Fig. 3A, lanes 1–6). The substrate can
equilibrate into numerous bubble, flap, double flap, and fold-
back flap structures (43, 44). Only a few of the many possible
structures have bubble configurations that produce a nick sus-
ceptible to ligation. Second, we tested a substrate with a nick in
which the 5 position was an abasic site (Fig. 2A, lanes 13–18).
Third, the substrate had a nickwith amismatched 5nucleotide
(Fig. 2B, lanes 1–6). In all cases, 9-1-1 stimulated ligase I activity
to the same extent (Fig. 2, A and B). These results suggest that
the stimulation is general, and not capable of altering substrate
specificity.
To further assess specificity we compared the effect of 9-1-1
on T4 ligase and DNA ligase I (Fig. 3 and data not shown).
Under our assay conditions, 9-1-1 enhancedDNA ligase I activ-
ity 6-fold and had no effect on T4 ligase (Fig. 3, lanes 4–8 and
data not shown). This suggests a stimulation specificity for
DNA ligase I. It is also consistent with the interpretation that
9-1-1 does not alter the structure of the substrate to make it
more efficient for ligation.
9-1-1 Promotes DNA Ligase I Binding to Nicked Substrates—
As with PCNA, the stimulation of ligation might be based on
improved affinity for the substrate. To test this possibility, we
assessed DNA ligase binding to the DNA substrate by a gel
mobility shift assay. The results showed that 9-1-1 enhances
DNA ligase I binding to nicked double-stranded DNA (Fig. 4,
lanes 4–6). There is virtually no ligase binding to intact double-
strandedDNAwithout 9-1-1, and onlymarginal binding is seen
with 9-1-1 (Fig. 4, lane 7). Interestingly, no 9-1-1 remains with
the DNA in the presence or absence of DNA ligase I. These
results are consistent with improvement of ligase binding to the
substrate or activation of more molecules of ligase for binding
activity.
9-1-1 Enhances the Sequential Action of FEN1 and DNA
Ligase I—FEN1 andDNA ligase I are thought to act sequentially
in LP-BER. Because 9-1-1 interacts with both components, it
might either enhance or interfere with their sequential func-
tions. To resolve this question, we designed a substrate to sim-
ulate an LP-BER intermediate formed during the strand dis-
placement synthesis step that pushes the 5 abasic site up into a
flap. Our substrate has an upstream primer and downstream
flap annealed to a template in such a way that FEN1 cleavage
would produce a nick for ligation. The upstream primer has an
unannealed 3-nucleotide creating themost favored double flap
structure for FEN1 cleavage. Addition of DNA ligase I alone
generated no product, verifying that the initial substrate has no
nicks (Fig. 5, lane 2). In the presence of a limiting amount of
FEN1 in the reaction to create nicks, a small amount of ligation
product was observed (Fig. 5, lane 4). Following the addition of
9-1-1 complex, both increased FEN1 cleavage product and liga-
tion product were observed, indicating that 9-1-1 stimulates
both FEN1 and DNA ligase I. Using the same amount of 9-1-1
complex, the stimulation of FEN1 alone was 1.7-fold of that in
the presence of DNA ligase I and FEN1 (Fig. 5, lanes 8 and 9).
This is consistent with the efficient use of the FEN1 product as
a substrate for ligation. These results show that 9-1-1 promotes
stepwise FEN1 cleavage and DNA ligase I activity.
Casein Kinase II Inhibits DNA Ligase I but Allows 9-1-1
Stimulation—Recent evidence indicates that phosphorylation
of DNA ligase I by CK2 reduces its activity (42, 45, 46). Simi-
FIGURE 1. 9-1-1 interacts with DNA ligase I in vivo and in vitro. A, Western
blot after immunoprecipitation. Human Rad9 antibody was used in immuno-
precipitation. Lane 1 shows untreated TK6 cells. Lane 2 shows -irradiation-
treated TK6 cells. Lane 3 shows UV-treated TK6 cells. Lane 4 shows untreated
cells immunoprecipitated by hemagglutinin antibody. The experiments were
performed twice. We set the ratio of DNA ligase I band density:Rad9 band
density as 1 in untreated cells. Average relative ratios from the two experi-
ments are 0.9 in IR-treated cells and 2.1 in UV-treated cells. After immunopre-
cipitation, samples were detected by human ligase I antibody (upper) and
human Rad9 antibody (lower). B, interaction between 9-1-1 and DNA ligase I
in vitro. Lane 1 shows histidine antibody-conjugated beads mixed with His-
tagged purified human DNA ligase I and human 9-1-1 complex. Lane 2 shows
histidine antibody-conjugated beads mixed with human 9-1-1 complex. Lane
3 shows His-tagged purified human DNA ligase I. Lane 4 shows human 9-1-1
complex alone. Lane 5 shows FLAG antibody-conjugated beads mixed with
human 9-1-1 and His-tagged purified human DNA ligase I. Lane 6 shows FLAG
antibody-conjugated beads mixed with His-tagged purified human DNA
ligase I. After immunoprecipitation, samples were detected by human ligase
I antibody and human Rad1 antibody.
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larly, it was found that CK2 phosphorylates the base excision
repair protein XRCC1, suggesting that CK2 has a direct role in
DNA repair (47). 9-1-1 stimulates ligation as expected in the
absence of CK2 (Fig. 6A, lanes 4 and 5). In the presence of CK2,
there is reduced ligation activity overall, but an enhancement
by 9-1-1 is still observed (Fig. 6A, lanes 9 and 10).Moreover, the
proportion of stimulation by 9-1-1 was approximately the
same. Comparing lanes 3 to 8 in Fig. 6A, we found that DNA
ligase I activity itself decreased by CK2. To clarify the effect of
CK2 on ligation, we titrated the kinase included in the reaction.
As shown in Fig. 6B, we observed that increased CK2 was pro-
gressively more inhibitory. DNA ligase I activity was almost
completely abolished in the highest concentration of CK2 (lane
7, 2milliunits/20l). In our previous studies, CK2was shown to
FIGURE 2. 9-1-1 stimulates DNA ligase I on different substrates. The proportion of ligation product was calculated according to the formula below: (density
of ligated DNA band  background)/((density of unligated DNA band  background)  (density of ligated DNA band  background)). We set the proportion
of the lane without enzyme as 0, the proportion of the lane with DNA ligase I alone as 1. A, left, for lanes 1– 6, an equilibrating CTG repeat substrate (D3:T2:U2)
was used. For lanes 7–12, a conventional nick substrate (D4:T3:U3) was used. For lanes 13–18, 1,2-dideoxyribose (dSpacer) nick substrate (D5:T3:U3) was used.
Lanes 1, 7, and 13 had substrates only. Lanes 2, 8, and 14 had substrate and 500 fmol of 9-1-1. Lanes 3, 9, and 15 had substrate and 2 fmol of DNA ligase I. Lanes
4, 10, and 16 had substrate, 2 fmol of DNA ligase I, and 100 fmol of 9-1-1. Lanes 5, 11, and 17 had substrate, 2 fmol of DNA ligase I, and 250 fmol of 9-1-1. Lanes
6, 12, and 18 had substrate, 2 fmol of DNA ligase I and 500 fmol of 9-1-1. The substrates were labeled at the 5-end of the downstream primer. The reactions were
performed at 37 °C for 10 min. Right, graph of –fold stimulation. Regular represents conventional nick substrate (D4:T3:U3). Triple repeat represents equilibrat-
ing CTG repeat substrate (D3:T2:U2). D spacer represents 1,2-dideoxyribose (dSpacer) nick substrate (D5:T3:U3). B, left, for lanes 1– 6, mismatch substrate
(D2:T1:U1) was used. For lanes 7–12, conventional nick substrate (D1:T1:U1) was used. Lanes 1 and 7 had substrate only. Lanes 2 and 8 had substrate and 500
fmol of 9-1-1. Lanes 3 and 9 had substrate and 2 fmol of DNA ligase I. Lanes 4 and 10 had substrate, 2 fmol of DNA ligase I, and 100 fmol of 9-1-1. Lanes 5 and 11
had substrate, 2 fmol of DNA ligase I, and 250 fmol of 9-1-1. Lanes 6 and 12 had substrate, 2 fmol of DNA ligase I, and 500 fmol of 9-1-1. The substrates were
labeled at the 5-end of the downstream primers. The reactions were performed at 37 °C for 10 min. Right, graph of –fold stimulation. Regular represents
conventional nick substrate (D4:T3:U3). Mismatch represents mismatch substrate (D2:T1:U1). nt, nucleotide.
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prevent PCNA from stimulating ligation activity by phospho-
rylating DNA ligase I (42). Here we showed that CK2 did not
inhibit 9-1-1 stimulation activity, but altered the basal level of
ligation activity indicating that the phosphorylation of DNA
ligase I affects its interactionswith these two clamps differently.
9-1-1 Can Stimulate DNA Ligase I without Encircling the
DNA—Proper loading of PCNA so that it encircles DNA is
carried out byRFC, anATP-dependent clamp loader (48). 9-1-1
can be loaded to encircle DNA by the variant RFC form Rad17-
RFC (7–9). To determine whether 9-1-1 has to encircle the
DNA to stimulate DNA ligase I, we employed primed x174
circular single-stranded DNA. As shown in Fig. 7, even without
Rad17-RFC and replication protein A, the addition of 9-1-1 still
leads to increased DNA ligase I activity (Fig. 7, lanes 10–12).
The degree of stimulation on the linear and circular substrates
was nearly the same. We conclude that stimulation does not
require 9-1-1 loading and encirclement of the DNA.
DISCUSSION
We previously proposed that 9-1-1 is a damage-specific
substitute for PCNA, in acting as a platform and coordina-
tion factor for DNA repair proteins (17). This possibility is
consistent with the proposed movement of 9-1-1 to damage
sites to serve its role as a damage sensor (49). It is also con-
sistent with its structural and functional resemblance to
PCNA. This hypothesis also offers an explanation for how
repair functions could be maintained during a damage
response in which p21 is induced and halts DNA replication
by inactivation of PCNA (1, 4, 5, 50). Moreover, recent
results show that 9-1-1 interacts with a variety of compo-
nents of LP-BER, and stimulates DNA polymerase , FEN1,
and DNA ligase I (15–19), indicative of direct participation
in DNA repair.
Our present observations support the proposed direct role of
FIGURE 3. 9-1-1 stimulates DNA ligase I but not T4 ligase. In the experi-
ments, the 5-end of the downstream primers of substrates were radiolabeled
using [-32P]ATP. Each reaction contained 10 fmol of substrate (D1:T1:U1).
Reactions were incubated at 37 °C for 10 min. Lane 1 contained just substrate.
Lane 2 contained substrate and 500 fmol of 9-1-1 complex. Lanes 3– 8 con-
tained substrate, 2 fmol of DNA ligase I, and 0, 25, 50, 100, 250, and 500 fmol of
9-1-1, respectively. The addition of 9-1-1 did not increase the amount of liga-
tion product generated by T4 ligase (data not shown). The proportion of
product was calculated as described in the legend of Fig. 2. nt, nucleotide.
FIGURE 4. 9-1-1 promotes ligase I binding to a nicked linear substrate.
Substrates were labeled at the 5-end of the upstream primers. Left, the effect
of 9-1-1 on DNA ligase I binding nicked linear DNA. In each reaction, 10 fmol of
nicked substrates (D1:T1:U1) were used. Lane 3 contained only substrate and
50 fmol of DNA ligase I. Lanes 4 – 6 contained 250, 500, and 1000 fmol of 9-1-1
besides substrates and 50 fmol of DNA ligase I. Right, the effect of 9-1-1 on
DNA ligase I binding to linear DNA lacking a nick. In each reaction, 10 fmol of
substrate (T1:U3) was used. Lane 9 contained only substrate and 50 fmol of
DNA ligase I. Lanes 10 –12 contained 250, 500, and 1000 fmol of 9-1-1 in addi-
tion to substrate and 50 fmol of DNA ligase I. More DNA ligase I binding to the
substrate was detected after addition of 9-1-1 compared with DNA ligase I
alone. The proportion of the DNA ligase I-DNA complex was calculated
according to the formula below: (density of bound DNA band  back-
ground)/(density of free DNA  background)  (density of bound DNA
band  background). We set the proportion of lane 3 as 1, and the proportion
of lanes 1 and 7 as 0. Other relative DNA binding values are shown in the
figure. nt, nucleotide.
FIGURE 5. 9-1-1 enhances the coordinated action of FEN1 and DNA ligase
I. In each reaction, 10 fmol of substrate (D6:T1:U1) was utilized. Reactions
were performed at 37 °C for 10 min as described under “Experimental Proce-
dures. ” Lane 3 contained 1 fmol of FEN1 and substrate only. Lane 4 contained
1 fmol of FEN1, 5 fmol of ligase I, and substrate. Lanes 4 – 8 contained 50, 100,
250, and 500 fmol of 9-1-1 in addition to 1 fmol of FEN1, 5 fmol of DNA ligase
I, and substrates. Lane 9 contained only 1 fmol of FEN1, 500 fmol of 9-1-1, and
substrate. The proportion of cleavage product was calculated according to
the formula below: (density of ligation product band  background)  (den-
sity of cleavage product band  background)/(density of substrate DNA
band  background)  (density of ligation product band  background) 
(density of cleavage product band  background). We set the proportion of
lane 1 as 0, the proportion of lane 3 as 1. Other relative DNA binding values are
shown in the figure. The proportion of ligation product was: (density of liga-
tion product band  background)/(density of substrate DNA band  back-
ground)  (density of ligation product band  background)  (density of
cleavage product band  background). We set the proportion of lane 1 as 0,
and the proportion of lane 4 as 1. Other relative DNA binding values are
shown in the figure. nt, nucleotide.
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9-1-1 in DNA repair. We show that 9-1-1 and DNA ligase I
co-immunoprecipitate from cell extracts. Significantly, UV
irradiation of the cells doubles the amount of 9-1-1/DNA ligase
I interaction. Interestingly, IR treatment does not increase the
amount of the complex. The damage caused by IR generates
double strand breaks (12, 51). Mutants that are defective in
double strand break repair, such as in RAD51, RAD52, Ku etc.,
are sensitive to IR. In double strand break repair, DNA ligase I is
thought to participate in homologous recombination, andDNA
ligase IV plays a key role in non-homologous end joining (12).
However, in human cells, 99% of
double strand break repair is per-
formed by non-homologous end
joining (52). This may be why the
DNA ligase I and 9-1-1 interaction
does not increase after IR treatment.
However, nucleotide excision repair
is themain pathway for repair of UV
damage. DNA ligase I acts on seal-
ing the nick formed at the last stage
of excision repair (12).
Both FEN1 andDNA ligase I bind
PCNA and respond with higher cat-
alytic activity (39, 40, 42, 53). There
is evidence that the PCNA tethers
these proteins to their substrates.
Results obtained here suggest that
9-1-1 also promotes binding of
DNA ligase I to its nickedDNA sub-
strate. Besides the conventional
nicked substrate, DNA ligase I has
activity on substrates that have mis-
matches at the nicked site, have modified nucleotides, or equil-
ibrate to a mixture of forms only some of which can be ligated.
Our results show that the stimulation is similar on all of these
substrate types. This suggests that the stimulation does not
involve a structural change in the ligase that alters substrate
specificity. One likely mechanism is that there is a general
improvement in the affinity for DNA. Another possibility is
that the ligase exists in several conformations, and the 9-1-1
promotes the most active conformation. This latter interpreta-
tion is consistent with the higher affinity of DNA ligase I for its
substrate seen in gel shift assays. This latter behavior is also
observed for PCNA stimulation of both FEN1 andDNA ligase I,
suggesting a similarity in the stimulation mechanisms (42, 53).
9-1-1was found to promote the conversion of a flap substrate
to a ligated product when both FEN1 and ligase were present in
the reaction. We have previously demonstrated that PCNA
promotes this sequential reaction, supporting the role of PCNA in
the final steps of Okazaki fragment processing (50). The similar
result with 9-1-1 is consistent with the proposed role of 9-1-1 in
the coordination of steps in long patch-base excision repair and
other repair reactions involving FEN1 and DNA ligase I.
Why would it be necessary to have two types of clamps for
FEN1 and DNA ligase I? As discussed earlier, the cellular
response to sufficient DNA damage is to stop DNA replication
but allow some level of DNA repair. This process involves the
induction of p21, which has a C-terminal domain designed to
bind and inactivate PCNA (1). If PCNAactivity were reduced, it
would be advantageous to have an alternative clamp for DNA
repair proteins. Although 9-1-1 stimulates FEN1 and DNA
ligase I activities, it does not stimulate DNA polymerase  or
promote highly processive synthesis like PCNA (16, 17). In this
way it displays specificity for stimulation of DNA repair but not
DNA replication. The recent observation that FEN1 has unique
binding sites for PCNA and 9-1-1 is consistent with this inter-
pretation (18). This supports the conclusion that FEN1 activity
is promoted independently by the two clamps. The additional
FIGURE 6. CK2 inhibits DNA ligase I but allows 9-1-1 stimulation. Each reaction contained 10 fmol of sub-
strate (D1:T1:U1). A, the addition of CK2 decreased the total amount of ligation products but did not affect
stimulation of DNA ligase I by the 9-1-1 complex. Levels of 250 and 500 fmol of 9-1-1 were used in lanes 4, 9 and
5, 10, respectively. Lanes 1–5 were in the absence of CK2. Lanes 6 –10 were in the presence of 1 milliunit of CK2.
B, CK2 inhibits DNA ligase I activity. Lanes 2–7 contained 5 fmol of DNA ligase I and 0, 0.05, 0.1, 0.5, 1, and 2
milliunits of CK2, respectively. For each figure, the proportion of product was calculated as described in the
legend of Fig. 2. nt, nucleotide.
FIGURE 7. 9-1-1 stimulates DNA ligase I on either a linear nicked substrate
or a closed circular substrate. Each reaction contained 10 fmol of substrate
and was performed at 37 °C for 10 min as described under “Experimental
Procedures.” Left, 9-1-1 stimulation on linear substrate (D1:T1:U1). Lane 1, sub-
strate only. Lane 2, substrate and 500 fmol of 9-1-1 complex. Lanes 3– 6, sub-
strate, 2 fmol of DNA ligase I, and 0, 100, 250, and 500 fmol of 9-1-1 complex,
respectively. Right, 9-1-1 stimulation on a closed circular substrate (D1:
X174:U1). Lane 7, substrate only. Lane 8, substrate and 500 fmol of 9-1-1
complex. Lanes 9 –12, substrate, 2 fmol of DNA ligase I, and 0, 100, 250, and
500 fmol of 9-1-1 complex, respectively. Substrate and ligation product sizes
were 30 and 59 nucleotides, respectively, as indicated. The proportion of
product was calculated as described in the legend of Fig. 2. nt, nucleotide.
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observation that acetylation of FEN1 prevents only 9-1-1 from
stimulation, suggests that independent sites have evolved so
that the actions of FEN1 in DNA replication and repair can be
regulated independently (18).
Treatment with high levels of CK2 strongly suppresses DNA
ligase I activity. In vivo, Ser-66, which is part of the consensus
site for phosphorylation by CK2, is phosphorylated during the
G2/M phase (54). DNA ligase I activity is low in G2/M phase. We
show that 9-1-1 still stimulates DNA ligase I activity even in the
presence of CK2, although CK2 abrogates DNA ligase I stimula-
tion by PCNA, indicating that 9-1-1 can stimulate DNA ligase I
even after phosphorylation at some sites (42). Phosphorylation of
Ser-66 is coincidentwith dissociation of PCNA fromDNA ligase I
(54).We suggest that during S phase, PCNA supports DNA repli-
cation and repair. During G2/M phase, PCNA cannot enhance
DNA ligase I activity because of the phosphorylation status of the
two proteins. Instead, 9-1-1 supports DNA ligase I in repair.
A striking difference between stimulation by PCNA and
9-1-1 is that PCNAmust be loaded to encircle the DNA before
it can stimulate FEN1 or DNA ligase I (42). However, 9-1-1
stimulateswith apparently the same efficiencywhether it is able
to load onto theDNAornot.We suggest several reasons for this
observation. Possibly, encirclement of the DNA is required for
9-1-1 checkpoint function. However, stimulation of ligation by
9-1-1 may derive from a protein-protein interaction that does
not involve encirclement. By this view the toroidal structure of
9-1-1 is misleading in that it has evolved for only one of the two
roles of the complex (55). Another possibility is that ligation
in vivo is normally stimulated by a 9-1-1 molecule loaded onto
theDNA.However, the stimulatory interaction site is still avail-
able when the 9-1-1 is free in solution. Therefore, when carry-
ing out the experiment with pure proteins, we can still observe
stimulation. However, in vivo, only the loading process raises
the local concentration of the 9-1-1 at the damage site enough
for it to function properly. This interpretation is consistentwith
the need for a substantial and similar molar excess of either
PCNA or 9-1-1 for stimulation of either DNA ligase I or FEN1
on linear substrates (17, 42, 53). In each case the molar excess
would be needed to simulate the effective concentration nor-
mally achieved by loading onto a circular or closed substrate.
Overall, our results support the hypothesis that the 9-1-1
checkpoint complex has a dual role in serving as a damage sen-
sor and a platform for DNA repair functions. This interpreta-
tion is consistent with its similarity to PCNA in both structure
and loading mechanism and its ability to bind and stimulate
DNA repair proteins. However, it is also clearly different from
PCNA in its specificity for FEN1 andDNA ligase I, but notDNA
polymerase . There is now evidence that it can stimulate both
FEN1 and DNA ligase I without encirclement of the DNA.
Clearly more biochemical and cell biological analyses will be
required to sort out the role of the 9-1-1 in DNA repair.
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